Eczema Sleep Study
We know these are challenging times and venturing out can be especially stressful. We want you to know that at CRCC we have implemented every safety measure possible to keep you safe and prevent the spread of Covid-19. Patient areas are continually disinfected, social distancing is enforced in our lobby, and all staff wear masks/gloves throughout the day. If you arrive for your appointment and wish to wear a mask, we will provide one for you as well.
Many patients with atopic dermatitis (AD, also known as eczema), especially if it is moderate to severe AD, have problems sleeping due to itching, scratching or skin pain. However, not enough data/evidence is available to know how sleep disturbance may change with AD treatment. We are looking for eligible candidates to volunteer for a study to collect data/evidence from patients like you who will be treated with dupilumab to evaluate whether or not dupilumab helps to improve sleep quality in AD patients.
To qualify you must be:
- 18 years old and older
- diagnosed by a physician at least 2 years ago
- At least 10% of body covered in eczema
- Itching from eczema is keeping you awake
- This is an FDA approved medication.
- No blood draws.
- Qualified recipients may receive compensation for their time.
If you are interested in participating in this study please complete the form below and we will be in touch with you soon.
Your information will be used for the sole purpose of qualifying you for this study. We will not, in any circumstances, share your personal information with other individuals or organizations without your permission.